Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Device Design & Manufacturing
dbglove.com

See what CB Insights has to offer

Stage

Seed | Alive

About INTACT

INTACT produces a device to help the visually impaired use a computer. It translates the Malossi alphabet into speech or transmits it over the internet. The user wears a dbGLOVE that consists of 18 sensitive areas that are mapped into distinct control signals, which can be utilized to represent letters and symbols.

INTACT Headquarter Location

Via Dieta di Bari 36

Bari, 70121,

Italy

+39 0809909637

Latest INTACT News

AMD’s Market Share Gain Story Remains Intact

Aug 8, 2019

AMD’s Market Share Gain Story Remains Intact Advanced Micro Devices (NASDQ: AMD ) stock jumped nearly 8% to $31.38 in Thursday’s early session after the company announced the release of Epyc 2, its newest chip for data centers. The chipmaker also said that it has won Alphabet’s Google (NASDAQ:GOOG, GOOGL) unit and Twitter (NASDAQ:TWTR) as customers. AMD makes processors for data centers that power internet-based services. It competes with Intel (NASDAQ:INTC) which has been a dominant force in the data center space and in the PC processor market for many years to supply chips that act as the main computing brains for PCs, servers, gaming and artificial intelligence. Apart from having ’only’ 32 billion transistors and as many as 64 cores, AMD said its 2nd Gen Epyc processors – largely thought to be a product that will allow the company to grab some serious data centers market share from Intel – deliver twice the price performance of Intel’s fastest available chips. Forrest Norrod, senior VP of the Datacenter and Embedded Solutions Business Group at AMD, said Epyc 2, code-named “Rome”, has twice the performance of Intel’s top chip at half the price. “Rome kicks ass,” he said. “The new standard for the datacenter is Epyc.” Last week, AMD reported earnings of $0.08 per share, matching Wall Street’s expectations. The Santa Clara, Calif.-based company posted revenue of $1.53 billion, compared to estimates of $1.52 billion. Guidance however, for the current quarter and full fiscal 2019 came in lower than expected. AMD provided 3Q19 revenue guidance of $1.8 billion +/- $50 million, lower than estimates of about $1.95 billion. Still, the new guidance – which was largely due to a weak semi-custom business – represents year-over-year growth of 9%. What’s more, AMD’s newest gen of server chips should allow it to continue to win new customers and as a result data center market share. In fact, Jefferies’s Mark Lipacis on Wednesday confirmed this assumption, anticipating in a note to investors a favorable server CPU upcycle ahead for AMD. The analyst said he expects the company to gain another 10 percentage points of server Micro Processing Unit share over the next 12 to 18 months. Lipacis, who has an buy rating rating and a $40 price target on AMD shares, noted that the chipmaker gained about 2 to 5 percentage points of chip share in the server, desktop, and notebook markets in 2Q19 versus 2Q18. Meanwhile, Paul Alcorn of tom’s hardware believes the unveiling of AMD’s EPYC 2 processors “marks not only the culmination of the company’s big bets made years in advance, shrewd go-to-market strategies, and clever engineering, but it could also mark the beginning of the biggest upset in semiconductor history.” As of writing, AMD stock, currently trading for more than 30x for 2019 non-GAAP earnings, is up $3.50, or 12.16%, to $32.70 in midday trading Thursday.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing INTACT

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

INTACT is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

7,884 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

INTACT Patents

INTACT has filed 5 patents.

The 3 most popular patent topics include:

  • Mathematical modeling
  • Numerical analysis
  • Numerical differential equations
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/29/2016

7/2/2019

Molecular biology, Genetics, Biotechnology, DNA, Transcription factors

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/29/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

7/2/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, Genetics, Biotechnology, DNA, Transcription factors

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.